Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Clinical trial NCT06892223 · RECRUITING

Trial details

NCT number: NCT06892223
Sponsor: Istituto Clinico Humanitas
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia MDS (Myelodysplastic Syndrome)MPN (Myeloproliferative Neoplasms)

Start date: 2021-12-03
Primary completion: 2025-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.